Hypertrophic cardiomyopathy epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 6: Line 6:
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*The incidence/prevalence of Hypertrophic cardiomyopathy is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of Hypertrophic cardiomyopathy was estimated to be [number range] cases per 100,000 individuals worldwide.


===Prevalence===
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*The incidence/prevalence of Hypertrophic cardiomyopathy is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of Hypertrophic cardiomyopathy was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*In [year], the incidence of Hypertrophic cardiomyopathy is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
*The case-fatality rate/mortality rate of Hypertrophic cardiomyopathy is approximately [number range].


===Age===
===Age===
*Patients of all age groups may develop [disease name].
*Patients of all age groups may develop Hypertrophic cardiomyopathy.
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*The incidence of Hypertrophic cardiomyopathy increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
*Hypertrophic cardiomyopathy commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
*There is no racial predilection to [disease name].
*There is no racial predilection to Hypertrophic cardiomyopathy.
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
*Hypertrophic cardiomyopathy usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop Hypertrophic cardiomyopathy.
===Gender===
===Gender===
*[Disease name] affects men and women equally.
*Hypertrophic cardiomyopathy affects men and women equally.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
*[Gender 1] are more commonly affected by Hypertrophic cardiomyopathy than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.


===Region===
===Region===
*The majority of [disease name] cases are reported in [geographical region].
*The majority of Hypertrophic cardiomyopathy cases are reported in [geographical region].


*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
*Hypertrophic cardiomyopathy is a common/rare disease that tends to affect [patient population 1] and [patient population 2].


===Developed Countries===
===Developed Countries===

Revision as of 22:15, 26 November 2019

Hypertrophic Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypertrophic Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypertrophic cardiomyopathy epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertrophic cardiomyopathy epidemiology and demographics

CDC on Hypertrophic cardiomyopathy epidemiology and demographics

Hypertrophic cardiomyopathy epidemiology and demographics in the news

Blogs on Hypertrophic cardiomyopathy epidemiology and demographics

Directions to Hospitals Treating Hypertrophic cardiomyopathy

Risk calculators and risk factors for Hypertrophic cardiomyopathy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]

Overview

Epidemiology and Demographics

Incidence

  • The incidence/prevalence of Hypertrophic cardiomyopathy is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of Hypertrophic cardiomyopathy was estimated to be [number range] cases per 100,000 individuals worldwide.

Prevalence

  • The incidence/prevalence of Hypertrophic cardiomyopathy is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of Hypertrophic cardiomyopathy was estimated to be [number range] cases per 100,000 individuals worldwide.
  • The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

  • In [year], the incidence of Hypertrophic cardiomyopathy is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of Hypertrophic cardiomyopathy is approximately [number range].

Age

  • Patients of all age groups may develop Hypertrophic cardiomyopathy.
  • The incidence of Hypertrophic cardiomyopathy increases with age; the median age at diagnosis is [#] years.
  • Hypertrophic cardiomyopathy commonly affects individuals younger than/older than [number of years] years of age.
  • [Chronic disease name] is usually first diagnosed among [age group].
  • [Acute disease name] commonly affects [age group].

Race

  • There is no racial predilection to Hypertrophic cardiomyopathy.
  • Hypertrophic cardiomyopathy usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop Hypertrophic cardiomyopathy.

Gender

  • Hypertrophic cardiomyopathy affects men and women equally.
  • [Gender 1] are more commonly affected by Hypertrophic cardiomyopathy than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

  • The majority of Hypertrophic cardiomyopathy cases are reported in [geographical region].
  • Hypertrophic cardiomyopathy is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

References

Template:WH Template:WS


References

Retrieved from "https://www.wikidoc.org/index.php?title=Hypertrophic_cardiomyopathy_epidemiology_and_demographics&oldid=1590377"